Madurella mycetoma: a neglected tropical disease

Baby, Poornima; Mohan, Vipin; Eapen, Malini; Kurian, Anna; Ramachandran, Arya; Babu, Balu C; Kumar, Anil

doi:10.1016/j.cmi.2021.04.018

Cited by 1 publication

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Eumycetoma may extend beyond the skin and subcutaneous tissues to adjacent structures, including muscle, bone and lymphatic vessels. Genetic predisposition to development of eumycetoma may be an important factor in pathogenesis [46]. The current recommended protocol in endemic areas with limited resources is to start with fine-needle aspiration cytology; if results are negative, the next appropriate step is deep surgical biopsy for culture and histopathological examination.…”

Section: Eumycotic Mycetomamentioning

confidence: 99%

Recent concepts in fungal involvement in skin and soft tissue infections

Peghin

Ruiz‐Camps

2021

Current Opinion in Infectious Diseases

View full text Add to dashboard Cite

As the at-risk population expands and new antifungal resistance patterns develop, it is critical to understand and recognize cutaneous manifestations of old and emerging fungal diseases. Purpose of reviewThe aim of this review is to provide an overview of the most frequent and emerging deep cutaneous fungal infections following either primary inoculation or secondary spread after haematogenous seeding in disseminated infections in different geographical areas. Recent findingsFungal skin and soft tissue infections (SSTIs) encompass a variety of pathological conditions based on the site of the infection, route of acquisition of the pathogen, epidemiological setting and the virulence of the fungus in relation to the host. The approach to a patient suspected of having a fungal SSTI is complex and usually poses a major diagnostic challenge. The treatment approach should include attempts at immune reconstitution, targeted antifungal therapy and/or aggressive surgical debridement. SummaryFungal SSTIs can be an important cause of morbidity and mortality in both immunocompromised and immunocompetent patients and are being reported with increasing frequency worldwide.

show abstract

Section: Eumycotic Mycetomamentioning

confidence: 99%